INTRODUCTION {#sec1-1}
============

Amiodarone (AD), an iodine-containing highly lipophilic benzofuran derivative, is a very effective class III, long-acting antiarrhythmic drug. It causes acute pneumonitis resulting in fatal pulmonary fibrosis.\[[@ref1]\] *In vivo* and *in vitro* studies have shown that AD is directly toxic to lung cells\[[@ref2]\] such as alveolar macrophages,\[[@ref3]\] alveolar epithelial cells,\[[@ref4]\] and pulmonary artery endothelial cells.\[[@ref5]\] AD and its primary metabolite N-desethylamiodarone have been demonstrated to cause apoptosis and necrosis in cultured alveolar type II cells.\[[@ref4]\] AD-induced pulmonary injury could include disruption of mitochondrial function and cellular adenosine triphosphate ATP levels,\[[@ref6]\] enhanced oxidative stress and increased production of reactive oxygen species,\[[@ref7][@ref8]\] activation of alveolar macrophages and cytokine release.\[[@ref9][@ref10][@ref11]\]

*Aronia melanocarpa* (Michx.) Elliot (black chokeberry) originates from the eastern parts of North America and East Canada. Its migration to Europe and the former Soviet Union occurred around 1900. *Aronia* is commonly used to produce fruit syrup, juice, jellies, tea, and wine. Chokeberry fruits are extremely rich in phenolic compounds: Procyanidins, flavonoids (mainly from the subclass of anthocyanins) and phenolic acids.\[[@ref12]\] A series of studies has investigated the antioxidant properties of *Aronia* juice, *Aronia* extract or its phenolic constituents using different well-established assays.\[[@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18]\] Fresh *Aronia* berries possess the highest antioxidant capacity among berries and other fruits investigated so far as measured with oxygen radical absorbance capacity.\[[@ref13][@ref15]\] Studies have demonstrated that flavonoids including anthocyanins possess anti-inflammatory activity due to the suppression of the release of pro-inflammatory cytokines such as tumor necrosis factor alpha and interleukins (interleukin IL-1 beta, IL-6, IL-8).\[[@ref19][@ref20]\]

There are numerous pathologic similarities between human and rodent lungs and as such, rodent model presents an excellent tool to investigate pathologic changes *in vivo*.\[[@ref21]\]

The aim of the study was to investigate the effect of *A. melanocarpa* fruit juice (AMFJ) in a rat model of AD-induced pulmonary toxicity.

MATERIALS AND METHODS {#sec1-2}
=====================

Experimental substances {#sec2-1}
-----------------------

AD hydrochloride and all other chemicals and reagents wereof analytical grade and were purchased from Sigma-Aldrich Company (Germany). The Quantikine Rat IL-6 and IL-10 immunoassay kits were from R and D Systems (USA).

AMFJ was produced from *A. melanocarpa* Elliot fruits grown in the Balkan Mountains, Bulgaria. They were handpicked in September, crushed and squeezed. The juice was filtered, pasteurized at 80°C for 10 min and stored at 0°C until the experiment. The contents of phenolic substances in 100 mL AMFJ were: Total phenolics, 709.3 ± 28.1 mg as gallic acid equivalents, determined spectrophotometrically according to the Folin-Ciocalteu procedure;\[[@ref22]\] total flavonoids, 189.4 ± 8.6 mg as catechin equivalents, measured by a colorimetric assay developed by Zhishen *et al*.;\[[@ref23]\] total anthocyanins, 106.8 ± 6.2 mg as cyanidin-3-glucoside equivalents, determined by a pH-differential spectrophotometry at pH 1.0 and pH 4.5;\[[@ref24]\] quercetin, 11.8 mg, measured by a high-performance liquid chromatography method.\[[@ref25]\] The values were the mean of duplicate determinations of three samples.

Animals and experimental treatments {#sec2-2}
-----------------------------------

The study was carried out on 96 male Wistar rats (weight 220-250 g, age 4 months). The animals were obtained from the Research and Laboratory Animal Breeding Center of Slivnitsa (Bulgaria) and were housed in the university animal quarters for 1 month at a temperature of 22°C ± 2°C and humidity of 50 ± 10%, given normal pelleted diet and water AD libitum.

All procedures concerning animal treatment and experimentation were conducted in compliance with the national laws and policies, in conformity with the international guidelines (European Economic Community EEC Council Directive 86/609, IL 358, 1, December 12, 1987).

The animals were divided into four groups of 24 rats. Each group was subdivided into four subgroups of six rats. One subgroup of each group was sacrificed on days 3, 5, 10, and 28 under thiopental anesthesia (50 mg/kg) after receiving the respective treatment in the course of 2, 4, 9, and 10 days, respectively. Group 1 (Control) received two intratracheal (i.t.) instillations of sterile distilled water (2 mL/kg) on days 0 and 2. The four subgroups of Group 1 received distilled water (10 mL/kg) orally through an orogastric cannula from day 1 to days 2, 4, 9, and 10, respectively. Group 2 (AD) received two i.t. instillations of AD (6.25 mg/kg, as a 3.125 mg/mL water solution) on days 0 and 2.\[[@ref26]\] The subgroups of Group 2 received distilled water (10 mL/kg) orally through an orogastric cannula from day 1 to days 2, 4, 9, and 10, respectively. Group 3(AD + AMFJ5) was treated with AD i.t. on days 0 and 2, and from day 1 to days 2, 4, 9, and 10 the respective subgroups received AMFJ orally at a dose of 5 mL/kg diluted with distilled water to a total volume of 10 mL/kg. Group 4 (AD + AMFJ10) was treated with AD i.t. on days 0 and 2, and from day 1 to days 2, 4, 9, and 10 the respective subgroups received AMFJ orally at a dose of 10 mL/kg.

AD was dissolved in distilled water at 60°C and allowed to cool to room temperature before the i.t. instillation.

Lung weight coefficient {#sec2-3}
-----------------------

The body weight and lung weight were measured for each animal. The lung weight coefficient (organ weight in mg/100 g body weight) was calculated.

Bronchoalveolar lavage {#sec2-4}
----------------------

Bronchoalveolar lavage fluid (BALF) was obtained on days 3, 5, and 10. Rats were sacrificed by exsanguination through cutting v. renalis. The chest was opened, and the lungs were perfused *in situ* via the right heart ventricle with saline (30 mL). Triple lavage of the left lung through the trachea with a total of 5 mL of saline was performed. The volume of fluid recovered ranged from 80% to 90% of the fluid introduced.

Cytological assays of BALF {#sec2-5}
--------------------------

One aliquot of the BALF was used for total cell count ×10^5^/L. The cells were removed by centrifugation at 300 × g for 10 min. The cell pellet was resuspended in 1 mL of saline. The cell differentials were analyzed using the procedure of Danos and Keebler, modified by Saltini *et al*.\[[@ref27]\] Cells were collected on nitrocellulose filters 25 mm in diameter with 5 μm pores (SWP-025-00 Catalogue number SMWP02500; Millipore Corp.) and were stained with H and E.

Biochemical assays of BALF {#sec2-6}
--------------------------

After centrifugation of BALF, the supernatant was used for the measurement of enzyme activities such as lactate dehydrogenase (LDH), acid phosphatase (AcP), and alkaline phosphatase (AlP) by the methods of Bergmeyer *et al*.\[[@ref28]\] Total protein content was measured by the method of Lowry *et al*.\[[@ref29]\] The enzyme activities are represented in U/L, and total protein in mg/mL of BALF.

Biochemical assays of lung homogenate {#sec2-7}
-------------------------------------

Lung homogenate was obtained from the right lung. The tissue was homogenized with potassium chloride KCl (1.15%) in 1:10 ratio. The homogenate was centrifuged (9000 × g, 30 min), and the supernatant was stored on ice. Malondialdehyde (MDA) content in nmol/g tissue was measured on days 3, 5, and 10 by the method of Ohkawa *et al*.\[[@ref30]\]

Hydroxyproline (HP) levels (in μg/mL) were measured in lung homogenate of rats sacrificed on day 28 as described by Bergman and Loxley.\[[@ref31]\] The method is based on the release of free HP from collagen by acid hydrolysis.

Immunological assays of rat serum {#sec2-8}
---------------------------------

The serum of the experimental animals was used for the measurement of IL-6 and IL-10 in pg/mL on days 3, 5, and 10 by the ELISA method in accordance with the immunoassay kits manufacturer\'s instructions.

Statistical analysis {#sec2-9}
--------------------

Results are presented as mean ± SEM. The data were tested by one-way ANOVA, followed by Dunnett\'s multiple comparison post-test to identify significant difference. A level of *P* \< 0.05 was considered significant. All analyses were performed using GraphPad Prism Statistical Software.

RESULTS {#sec1-3}
=======

The lung weight coefficient {#sec2-10}
---------------------------

The lung weight coefficient of rats treated with AD was significantly higher than the control values on days 3 (*P* \< 0.01), 5 (*P* \< 0.001), and 10 (*P* \< 0.001). It increased gradually with time and on day 10 it reached 204% compared to the control value \[[Table 1](#T1){ref-type="table"}\]. The lung weight coefficients of rats treated with the two AMFJ doses were significantly lower in comparison with the respective AD groups on days 5 (*P* \< 0.001) and 10 (*P* \< 0.01), and did not differ significantly from those of the respective controls \[[Table 1](#T1){ref-type="table"}\].
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Cytological assays of BALF {#sec2-11}
--------------------------

The total cell count in BALF of rats from AD group increased dramatically on day 3 (368% of the control value), then gradually decreased. On day 5, it was 186% of the control level and on day 10 it was still higher (but not significantly) than the control value \[[Table 1](#T1){ref-type="table"}\]. AMFJ at both doses effectively antagonized that effect of AD, and in AMFJ-treated rats the total cell counts on days 3, 5, and 10 did not differ significantly from those of the respective controls \[[Table 1](#T1){ref-type="table"}\].

AD caused a dramatic increase of the polymorphonuclear leukocytes (PMNs) on day 3 (27 times higher than those of the control group; *P* \< 0.001 vs. control). After that PMNs gradually decreased, but remained about 12 times higher than the control value on day 5 (*P* \< 0.001 vs. control) and about 5 times higher than the control on day 10 (*P* \< 0.01 vs. control) \[[Table 1](#T1){ref-type="table"}\]. AD increased also the percentage of PMNs from the total cell count in BALF on days 3, 5, and 10 to values 63.47%, 34.28%, and 21.02%, respectively, while the control values at these time points were 8.60%, 5.30%, and 6.13% \[[Table 1](#T1){ref-type="table"}\]. AMFJ treatment significantly attenuated the effect of AD on PMNs. In AMFJ-treated rats, the counts of PMNs did not differ significantly from the respective controls on days 3, 5, and 10, and were significantly lower than those of the respective AD groups \[[Table 1](#T1){ref-type="table"}\]. For these rats, the percentage of PMNs from the total cell count at all-time points was considerably lower in comparison with the respective AD groups \[[Table 1](#T1){ref-type="table"}\].

Neither AD, nor AMFJ treatment significantly affected the number of alveolar macrophages (AMs) in BALF \[[Table 1](#T1){ref-type="table"}\]. In AD group, the percentages of these cells from the total cell count on days 3, 5, and 10 were 26.04%, 52.85%, and 66.43%, respectively. They were considerably lower in comparison with the control values, which at these time points were 87.80%, 91.09%, and 89.35% \[[Table 1](#T1){ref-type="table"}\]. In AMFJ-treated rats, the percentage of AMs was decreased to a certain extent on day 3 and almost returned to the control values on days 5 and 10 \[[Table 1](#T1){ref-type="table"}\].

In AD-treated rats, the lymphocyte (LYM) count in BALF significantly increased on days 3 (*P* \< 0.001 vs. control), 5 (*P* \< 0.01 vs. control) and 10 (*P* \< 0.05 vs. control) \[[Table 1](#T1){ref-type="table"}\]. Thus, AD caused an elevation of the percentage of LYMs from the total cell count in BALF on days 3, 5, and 10 to values of 10.53%, 12.52%, and 12.63%, respectively, while the control values for these time points were 3.58%, 3.75%, and 4.53% \[[Table 1](#T1){ref-type="table"}\]. The number of LYMs in AD + AMFJ5 and AD + AMFJ 10 groups did not differ significantly from that of the respective controls and their percentage from the total number of cells was similar to that of the controls \[[Table 1](#T1){ref-type="table"}\].

Biochemical assays of BALF {#sec2-12}
--------------------------

In AD group, the total protein content in BALF increased abruptly and on day 3 it was 518% of the control value (*P* \< 0.001 vs. control). It gradually decreased, so that on day 5 it was 365% of the control level (*P* \< 0.001 vs. control) and on day 10 it was still higher, but did not differ significantly from the control value \[[Table 2](#T2){ref-type="table"}\]. AMFJ at both doses prevented the AD-induced increase of total protein content in BALF. In AMFJ-treated rats, the total protein levels at all-time points did not differ significantly from those of the controls with the exception of AD + AMFJ5 group on day 3 (*P* \< 0.01 vs. control) \[[Table 2](#T2){ref-type="table"}\].
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The enzyme activities in BALF are shown in [Table 2](#T2){ref-type="table"}. LDH activity is a general marker of cell damage. Following AD instillation, LDH activity in BALF was elevated, being about 3 times higher than the control level on day 3 (*P* \< 0.001 vs. control), about 2 times higher on day 5 (*P* \< 0.001 vs. control) and about 1.5 times higher on day 10. AMFJ dose-dependently effectively prevented AD-induced increase in LDH activity, so that this enzyme activity was significantly higher compared to the control value (*P* \< 0.05) just in AD + AMFJ5 group on day 3.

The effect AD on AcP activity was similar to its effect on LDH activity. AcP activity was increased in AD group, and this increase was significant on day 3 (177%, *P* \< 0.01 vs. control) and day 5 (170%, *P* \< 0.01 vs. control). This increase in enzyme activity was counteracted by AMFJ treatment to such an extent that in AMFJ-treated animals, AcP activity at all-time points was not significantly different from the respective controls \[[Table 2](#T2){ref-type="table"}\].

A significant increase in AlP activity was observed in BALF of AD group on days 3 (260%, *P* \< 0.01 vs. control) and 5 (266%, *P* \< 0.001 vs. control). AMFJ dose-dependently prevented AD-induced increase in AlP activity and in AMFJ-treated animals this enzyme activity was significantly higher (*P* \< 0.05) than the control level just in AD + AMFJ5 group on day 5 \[[Table 2](#T2){ref-type="table"}\].

Biochemical assays of lung homogenate {#sec2-13}
-------------------------------------

AD caused an increase in MDA content in lung tissue, which was significant (*P* \< 0.01) on day 5 (196% of the control value). Both doses of AMFJ prevented this increase. On day 5, MDA level in AMFJ-treated rats did not differ significantly from the respective control value and was significantly lower (*P* \< 0.01) in comparison with that of the respective AD group \[[Figure 1](#F1){ref-type="fig"}\].

![Effect of *Aronia melanocarpa* fruit juice at doses of 5 mL/kg and 10 mL/kg on malondialdehyde levels in rat lung tissue 3, 5 and 10 days after intratracheal instillation of amiodarone (AD). \*\**P* \< 0.01 versus control; and ^&&^*P* \< 0.01 versus AD](PM-10-132-g003){#F1}

HP levels in lung tissue were measured on day 28. They are presented in [Figure 2](#F2){ref-type="fig"}. In rats from AD group, there was a significant increase in HP levels (147% of the control value; *P* \< 0.01 vs. control). In rats from AMFJ-treated groups (AD + AMFJ5 and AD + AMFJ10) the HP levels did not differ significantly from the control value. In rats from AD + AMFJ10 group, the HP level was significantly lower (*P* \< 0.05) than that of AD group.

![Effect of *Aronia melanocarpa* fruit juice at doses of 5 mL/kg and 10 mL/kg on hydroxyproline levels in rat lung tissue 28 days after intratracheal instillation of amiodarone (AD). \*\**P* \< 0.01 versus control; and ^&^*P* \< 0.05 versus AD](PM-10-132-g004){#F2}

Immunological assays of rat serum {#sec2-14}
---------------------------------

AD instillation resulted in an elevation of IL-6 in rat serum which was significant on day 3 (136% of the control; *P* \< 0.01 vs. control) and day 5 (116% of the control; *P* \< 0.05 vs. control) \[[Figure 3](#F3){ref-type="fig"}\]. AMFJ dose (10 mL/kg), which was tested for this effect, prevented AD-induced elevation of IL-6. In AMFJ-treated animals, the levels of IL-6 were significantly lower than those of AD group (*P* \< 0.05 on days 3 and 5; *P* \< 0.001 on day 10). IL-6 level on day 10 was even significantly lower than the control value (*P* \< 0.001).

![Effect of *Aronia melanocarpa* fruit juice at a dose of 10 mL/kg on IL-6 levels in rat serum 3, 5 and 10 days after intratracheal instillation of amiodarone (AD). \**P* \< 0.05 versus control; \*\**P* \< 0.01 versus control; \*\*\**P* \< 0.001 versus control; *P* \< 0.05 versus AD (Day 3); *P* \< 0.05 versus AD (Day 5); and ^&&&^*P* \< 0.001 versus AD (Day 10)](PM-10-132-g005){#F3}

In AD group, a reduction of IL-10 in rat serum was observed on days 3, 5, and 10 \[[Figure 4](#F4){ref-type="fig"}\]. This reduction was statistically significant on day 3 (*P* \< 0.05 vs. control). The tested dose of AMFJ (10 mL/kg) antagonized that effect of AD on IL-10. In AMFJ-treated animals, IL-10 levels did not differ significantly from the control value \[[Figure 4](#F4){ref-type="fig"}\].

![Effect of *Aronia melanocarpa* fruit juice at a dose of 10 mL/kg on IL-10 levels in rat serum 3, 5 and 10 days after intratracheal instillation of amiodarone. \**P* \< 0.05 versus control](PM-10-132-g006){#F4}

DISCUSSION {#sec1-4}
==========

Both indirect and direct toxic effects on target cells have been proposed for explanation of AD-induced pulmonary toxicity. AD has been demonstrated to cause membrane destabilization and increased intracellular influx of Ca^2+^,\[[@ref32]\] mitochondrial dysfunction,\[[@ref6]\] and overproduction of reactive oxygen species.\[[@ref7][@ref8]\] Numerous data show the role of oxidative stress in AD-induced lung fibrosis.\[[@ref33]\] Free radical reactions have been suggested to play a contributory role in the fibrogenesis either directly or through inflammatory stimuli. Lipid peroxidation and certain lipid peroxidation products induce genetic overexpression of fibrogenic cytokines, the key molecules in the mechanisms of fibrosis, as well as increased transcription and synthesis of collagen.\[[@ref34]\] Both these events can be down-regulated, at least in experimental models, by the use of antioxidants. Consequently, both catalytic and scavenger antioxidants have been shown to attenuate AD-induced lung injury and fibrosis in animals.\[[@ref34]\] Other findings show that activation of macrophages and release of inflammatory and cytotoxic mediators drive AD-induced lung fibrosis.\[[@ref10][@ref11]\]

The present study investigated the effect of AMFJ in pulmonary tissue in a rat model of AD-induced pneumotoxicity. All cytological investigations of BALF, as well as the biochemical investigations of BALF and lung homogenate, showed a well-expressed protective effect of AMFJ.

Taylor *et al*.\[[@ref2]\] have demonstrated that AD instillation produces a rapid and massive damage to the alveolar-capillary barrier and damage or death to lung airway and parenchymal cells. In this experiment, AD-induced lung impairment increased the permeability of pulmonary epithelium and endothelium, resulting in extravasation of plasma proteins. Thus, AD caused a significant elevation of the protein content of cell-free BALF on days 3 and 5 to levels, which were respectively 5 and almost 4 times higher than the control ones. AMFJ prevented the disturbance of alveolar-capillary barrier permeability, assessed by the level of protein in BALF. The protein content in BALF of AMFJ-treated rats was comparable to the respective control levels. This effect of AMFJ might be a result of the incorporation of its biologically active polyphenols into vascular walls. This suggestion is in coincidence with the finding that vascular endothelial cells can incorporate anthocyanins into the membrane and cytosol, conferring significant protective effects against oxidative insult.\[[@ref35]\]

The cytologic investigation of BALF suggested that AD caused substantial changes. They were most prominent on days 3 and 5 and resolved thereafter. AD caused an increase in the total cell count in BALF due to the rapid and massive damage to the alveolar-capillary barrier. AMFJ prevented that effect. In AD-treated rats, the number of PMNs dramatically increased. The influx of PMNs (marker of inflammation) into the interstitium and the bronchoalveolar space is considered to play a key role in the progression of acute lung injury.\[[@ref36]\] PMNs are the main participants in the acute inflammatory response in tissues, being recruited from the circulation when local defenses are overwhelmed. Stimulated neutrophils are cleared from the inflamed sites by apoptosis (programmed cell death) and following macrophage phagocytosis, which is the key process in the inflammation resolution.\[[@ref37]\] PMNs can possibly play a role in the inflammatory reaction by releasing growth factors and cytokines, as well as by releasing oxidants as a part of the host-defense system. In this study, the cytological investigations showed that AMFJ markedly diminished the number of PMNs in BALF. Thus, it suppressed the initial inflammatory response induced by AD, including migration and activation of inflammatory cells and disruption of the alveolar-capillary barrier. Acting on early, transient inflammation and damage of alveolar-capillary barrier, AMFJ could protect from further development of lung injury and fibrosis. Other investigations have demonstrated that the juice possesses also a pro-apoptotic effect in neutrophils by increasing caspase-3 activity, a marker of apoptosis execution.\[[@ref38]\]

Consistent with the development of pulmonary inflammation and edema, i.t. AD administration was accompanied by a progressive increase in the lung weight coefficient. AMFJ prevented that increase.

The elevated levels of some enzyme activities in BALF have long been recognized as markers of toxic pulmonary lesions: LDH - of increased membrane permeability and frank cell lysis, AlP - of toxic damage or proliferation of pneumocytes type 2, and AcP - of enhanced phagocytic activity or cell killing.\[[@ref39][@ref40]\]

In this study, AD significantly increased the activity of LDH and AcP in BALF on days 3 and 5, and these results confirmed its pneumotoxic effect shortly after treatment. The enzymes leak from dead or damaged cells, when membrane integrity is lost. The activity of AlP in BALF was also elevated on days 3 and 5 in AD-treated rats. This finding suggests early toxic effects and proliferation of pneumocytes type 2 during the recovery period. The data from the present study are consistent with other studies that have demonstrated elevated levels of enzymes in AD-treated rats.\[[@ref26]\] AMFJ prevented the early AD-induced increase in enzyme activities. This effect might be a result of the potent antioxidant properties of AMFJ due to which it could protect cellular membranes from oxidative damage and reduce membrane permeability.

The oxidative damage induced by AD was demonstrated by the increased lipid peroxidation measured by MDA levels, which were significantly elevated on day 5. AMFJ entirely prevented that effect of AD probably due to its pronounced antioxidant and radical scavenging activities, demonstrated by many authors\[[@ref12][@ref13][@ref14][@ref15][@ref16][@ref17][@ref18]\] and reviewed by Chrubasik *et al*.\[[@ref41]\] and Kokotkiewicz *et al*.\[[@ref42]\] The experiments of Zielinska-Przyjemska *et al*.\[[@ref37]\] have shown that *Aronia* juice and its active fractions significantly decrease the oxidative metabolism of PMNs. As free radicals play a crucial role in the pathogenesis of AD toxicity,\[[@ref7]\] we could suppose that the protective effect of AMFJ in this experiment might be predominantly due to its antioxidant and free radical scavenging properties. These findings are in accordance with other investigations demonstrating that other phenolic antioxidants (butylated hydroxyanisole, curcumin, grape seed procyanidins) are effective in limiting AD-induced reactive oxygen species generation and lung injury.\[[@ref43][@ref44][@ref45]\] There are also literature data for the the cytoprotective role of vitamin C and N-acetyl cysteine in AD-induced cytotoxicity on cell culture media.\[[@ref46]\] Both agents are commonly used in the clinical setting for different purposes incontext of their well-known antioxidant actions.\[[@ref46]\]

There are no literature data on the effect of AD on IL-6 and IL-10 levels. IL-6 is a potent, pleiotropic, inflammatory cytokine secreted by T cells and macrophages. IL-6 seems to play an important role in initiation and progression of fibrosis.\[[@ref47]\] In this study, AD caused a significant increase of serum IL-6, which might be a result of IL-6 translocation from the lung tissue to the circulation.\[[@ref48]\] AMFJ prevented AD-induced increase in IL-6. This effect is consistent with the anti-inflammatory activity of the flavonoids, which are essential juice constituents,\[[@ref19][@ref20]\] and correlates with the other effects of AMFJ on the indices of AD-induced lung injury. IL-10 is one of the most important cytokines with anti-inflammatory properties. Today it is known that the ability to synthesize IL-10 is not limited to certain T cell subsets, but is a characteristic of almost all leukocytes.\[[@ref49]\] Synthesis of IL-10 usually occurs as a consequence of acute and chronic inflammatory responses, and neutralization of IL-10 often exacerbates inflammatory lesions.\[[@ref50]\] AD induced a decrease of IL-10 in rat serum while AMFJ antagonized that effect of AD.

Since, the lung HP is almost exclusively derived from collagen,\[[@ref51]\] whole lung collagen content was estimated by measuring HP levels. The fibrotic response in the AD group was confirmed by a significant increase in lung HP above the control value on day 28. AMFJ applied in the first 10 days not only reduced the signs of inflammation, but also suppressed the fibrotic response as a result of which HP levels in rat groups treated with AMFJ did not differ from the control one.

CONCLUSION {#sec1-5}
==========

The present study demonstrated that AMFJ could have a protective effect in a rat model AD-induced pneumotoxicity. It increased the resistance of alveolar-capillary membrane to AD-induced damage and reduced the signs of oxidative stress and inflammation. That effect of AMFJ is probably due to its antioxidant and anti-inflammatory properties. Administered in the early inflammatory phase, AMFJ could protect the animals against AD-induced pulmonary fibrosis.
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